Skip to main content
. 2014 May 29;15:62. doi: 10.1186/1471-2350-15-62

Table 2.

Comparison of clinical features of 2q23.1 deletion in this study and other cohorts or MBD5 specific mutation

Clinical Features
MBD5-specific mutation 20,22–24
2q23.1 Deletion 20,22–24
Case in this study
  Number Percentage Number Percentage +, present; - absent
Neurological
 
 
 
 
 
 Development delay
20/21
95%
53/55
96%
+
 Language impairment
12/21
57%
38/55
69%
+
 Seizure
11/21
52%
32/55
58%
+
 Infantile spasms
0/21
0
0/55
0
+
 Infantile hypotonia
4/21
19%
23/55
41%
+
Growth/Endocrine
 
 
 
 
 
 Short stature
5/21
24%
25/55
45%
-
 Local hirsutism
0/21
0
4/55
7%
-
Craniofacial abnormalities
 
 
 
 
 
 Coarse face
0/21
0
3/55
5%
+
 Broad forehead
3/21
14%
4/55
7%
+
 Microcephaly
1/21
5%
26/55
47%
+(<2SD)
 Synophrys
2/21
9%
10/55
18%
+mild
 Nasal abnormalities
7/21
33%
35/55
64%
+
 Open mouth
3/21
14%
23/55
42%
+
 Downturned corners of the mouth
3/21
14%
17/55
31%
+
 Macroglossia or protruding tongue
2/21
9%
6/55
11%
-
 Dental abnormalities
4/21
19%
13/55
24%
 
Skeletal abnormalities
 
 
 
 
+
 Small hands and feet
1/21
5%
23/55
42%
+
 Clinodactyly, 5th finger
2/21
9%
22/55
40%
+
 Brachydactyly
0/21
0
13/55
24%
+
 Short fifth digit of hands/feet
1/21
5%
14/55
25%
+
 Absent hallux
0/21
0
0/55
0
+
Behaviors
 
 
 
 
-
 Autistic feature
13/21
62%
44/55
80%
+
 Sleep disturbance
5/21
24%
17/55
31%
ND
 Self-injurious behavior
2/21
9%
17/55
31%
+
Other
 
 
 
 
-
 Cardiovascular abnormalities
1/21
5%
4/55
7%
-
 Urogenital abnormalities 1/21 45% 1/55 2% -

ND, not documented.